|
Pons-Fuster E, Bernal E, Guillamon CF, Gimeno L, Martinez-Sanchez MV, Ruiz-Lorente I, Campillo JA, Ceballos D, Torres A, Tomas C, Munoz A, Alcaraz A, Selma P, Ruiz-Nicolas C, Muro M, Minguela A. HLA-C*07 is associated with symptomatic HIV-1-associated neurocognitive disorders (HAND) and immune dysregulation. Infect Dis (Lond). 2024 Oct;56(10):818-829. doi: 10.1080/23744235.2024.2351047. Epub 2024 May 14. PubMed PMID: 38743055.
AÑO: 2024; IF: 2.3
|
|
López-Jornet P., Hynninen J.N., Parra-Perez F., Peres-Rubio C., Pons-Fuster E., Tvarijonaviciute A. The Role of Salivary Biomarkers in Monitoring Oral Health in Patients with Implants and Periodontitis. Applied Sciences (Switzerland). January 2024. 14. 10.3390/app14020927
AÑO: 2024; IF: 2.5
|
|
Pons-Fuster E, Lozano-Caballero O, Martin-Balbuena S, Lucas-Rodenas C, Mancebo-Gonzalez A, De Gorostiza-Frias I, Gonzalez-Ponce CM. Anti‑CGRP monoclonal antibodies in resistant migraine: preliminary real-world effectiveness and clinical predictors of response at two years. Int J Clin Pharm. 2024 Dec;46(6):1317-1326. doi: 10.1007/s11096-024-01758-2. Epub 2024 Jul 11. PubMed PMID: 38990457.
AÑO: 2024; IF: 3.2
|
|
Ruiz-Lorente I, Gimeno L, Lopez-Abad A, Lopez Cubillana P, Fernandez Aparicio T, Asensio Egea LJ, Moreno Aviles J, Donate Iniguez G, Guzman Martinez-Valls PL, Server G, Escudero-Bregante JF, Ferri B, Campillo JA, Pons-Fuster E, Martinez Hernandez MD, Martinez-Sanchez MV, Ceballos D, Minguela A. Exploring the Immunoresponse in Bladder Cancer Immunotherapy. Cells. 2024 Nov 22;13(23):1937. doi: 10.3390/cells13231937. PubMed PMID: 39682686; PubMed Central PMCID: PMC11640729.
AÑO: 2024; IF: 5.2
|
|
Garcia Martinez A, Lopez-Jornet P, Pardo Marin L, Pons-Fuster E, Tvarijonaviciute A. Burning Mouth Syndrome Treated with Low-Level Laser and Clonazepam: A Randomized, Single-Blind Clinical Trial. Biomedicines. 2024 May 9;12(5):1048. doi: 10.3390/biomedicines12051048. PubMed PMID: 38791010; PubMed Central PMCID: PMC11118462.
AÑO: 2024; IF: 3.9
|